Sökning: L773:1021 335X OR L773:1791 2431
> (2010-2014) >
Wwox expression may...
Wwox expression may predict benefit from adjuvant tamoxifen in randomized breast cancer patients
-
- Göthlin Eremo, Anna, 1980- (författare)
- Örebro universitet,Institutionen för hälsovetenskap och medicin,Region Örebro län,University of Örebro, Sweden
-
- Wegman, Pia, 1964- (författare)
- Örebro universitet,Institutionen för hälsovetenskap och medicin,University of Örebro, Sweden
-
- Stål, Olle (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US
-
visa fler...
-
- Nordenskjöld, Bo (författare)
- Östergötlands Läns Landsting,Linköpings universitet,Avdelningen för kliniska vetenskaper,Hälsouniversitetet,Onkologiska kliniken US
-
- Fornander, Tommy (författare)
- Karolinska Institutet,Stockholm South Gen Hospital, Sweden
-
- Wingren, Sten, 1950- (författare)
- Örebro universitet,Institutionen för hälsovetenskap och medicin,University of Örebro, Sweden
-
visa färre...
-
(creator_code:org_t)
- 2013-01-31
- 2013
- Engelska.
-
Ingår i: Oncology Reports. - Athens, Greece : Spandidos Publications. - 1021-335X .- 1791-2431. ; 29:4, s. 1467-1474
- Relaterad länk:
-
https://doi.org/10.3...
-
visa fler...
-
https://www.spandido...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
http://kipublication...
-
https://urn.kb.se/re...
-
visa färre...
Abstract
Ämnesord
Stäng
- Reduced or absent Wwox expression has recently been associated with tamoxifen resistance in breast cancer and has also been proposed as a candidate predictive marker for treatment. We aimed to investigate the correlation of Wwox expression with the outcome of tamoxifen treatment by examining tissues from 912 randomized breast cancer patients. Paraffin-embedded tissues from patient tumors were arranged on tissue microarray, and Wwox protein was stained using immunohistochemistry. After microscopic examination, the results were analyzed with Cox regression, Kaplan-Meier survival curves and the log-rank test. In the group of cases having a tumor absent for Wwox expression, there was no difference in recurrence-free survival between treated and untreated patients (P=0.81). For treated cases with a tumor expressing moderate or strong Wwox protein, recurrence-free survival was improved (P=0.001 and P=0.003, respectively). The test for interaction between Wwox and treatment response demonstrated a decreased risk of recurrence for treated patients with a moderate or strong Wwox expression (HR=0.31, 95% CI 0.10-0.98 and HR=0.28, 95% CI 0.08-0.97, respectively). Our results indicate that patients with high expression of Wwox may gain more benefit from treatment with tamoxifen.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cancer and Oncology (hsv//eng)
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Nyckelord
- Wwox
- breast cancer
- tamoxifen
- randomized patients
- Biomedicin
- Biomedicine
- MEDICINE
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas